Research Article

Retrospective Analysis of Adoptive TIL Therapy plus Anti-PD1 Therapy in Patients with Chemotherapy-Resistant Metastatic Osteosarcoma

Table 2

Treatment-related adverse events in patients in response to therapy ().

Side effectsNo. (%) of patients associated with adverse events
Grade 1 or 2Grade 3 or 4

Fever30 (50)2 (3.33)
Fatigue15 (25)0
Rash11 (18.33)0
Anorexia13 (21.67)0
Leukopenia9 (15)0
Anemia8 (13.33)0
Vitiligo00
Nausea00
Vomiting00
Total incidence43 (71.67)2 (3.33)